CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 42 filers reported holding CIDARA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $759,493 | -7.6% | 805,871 | +10.7% | 0.00% | – |
Q2 2023 | $822,312 | -1.8% | 727,710 | +10.3% | 0.00% | – |
Q1 2023 | $837,777 | +186903.8% | 659,667 | +11.3% | 0.00% | – |
Q4 2022 | $448 | -99.9% | 592,724 | +1.3% | 0.00% | – |
Q3 2022 | $367,000 | +49.8% | 584,981 | +16.5% | 0.00% | – |
Q2 2022 | $245,000 | -38.1% | 502,049 | +5.5% | 0.00% | – |
Q1 2022 | $396,000 | -18.2% | 476,076 | +24.8% | 0.00% | – |
Q4 2021 | $484,000 | -43.3% | 381,618 | 0.0% | 0.00% | – |
Q3 2021 | $854,000 | +16.2% | 381,618 | +4.8% | 0.00% | – |
Q2 2021 | $735,000 | -53.2% | 364,162 | -38.3% | 0.00% | – |
Q1 2021 | $1,570,000 | +72.3% | 590,368 | +29.5% | 0.00% | – |
Q4 2020 | $911,000 | -28.6% | 455,736 | +1.7% | 0.00% | – |
Q3 2020 | $1,276,000 | -21.2% | 448,082 | +2.1% | 0.00% | – |
Q2 2020 | $1,619,000 | +197.1% | 438,754 | +99.4% | 0.00% | – |
Q1 2020 | $545,000 | -39.7% | 220,009 | -6.6% | 0.00% | – |
Q4 2019 | $904,000 | +291.3% | 235,476 | +103.0% | 0.00% | – |
Q3 2019 | $231,000 | +106.2% | 115,992 | +73.2% | 0.00% | – |
Q2 2019 | $112,000 | -32.1% | 66,975 | +7.5% | 0.00% | – |
Q1 2019 | $165,000 | -43.5% | 62,280 | -50.0% | 0.00% | – |
Q4 2018 | $292,000 | +6.6% | 124,560 | +100.0% | 0.00% | – |
Q3 2018 | $274,000 | -15.2% | 62,280 | 0.0% | 0.00% | – |
Q2 2018 | $323,000 | +85.6% | 62,280 | +42.5% | 0.00% | – |
Q1 2018 | $174,000 | -41.4% | 43,691 | 0.0% | 0.00% | – |
Q4 2017 | $297,000 | -23.5% | 43,691 | -9.0% | 0.00% | – |
Q3 2017 | $388,000 | +8.1% | 47,992 | 0.0% | 0.00% | – |
Q2 2017 | $359,000 | -33.8% | 47,992 | -31.0% | 0.00% | – |
Q1 2017 | $542,000 | -24.8% | 69,547 | +0.2% | 0.00% | – |
Q4 2016 | $721,000 | +65.4% | 69,420 | +82.2% | 0.00% | – |
Q3 2016 | $436,000 | +16.9% | 38,110 | +5.2% | 0.00% | – |
Q2 2016 | $373,000 | +8.7% | 36,240 | +34.1% | 0.00% | – |
Q1 2016 | $343,000 | -24.3% | 27,025 | +2.2% | 0.00% | – |
Q4 2015 | $453,000 | +64.7% | 26,448 | +22.0% | 0.00% | – |
Q3 2015 | $275,000 | – | 21,687 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,189,000 | 4.48% |
Omega Fund Management, LLC | 1,508,794 | $3,546,000 | 2.63% |
ALETHEA CAPITAL MANAGEMENT, LLC | 482,357 | $1,134,000 | 1.65% |
Opaleye Management Inc. | 1,200,000 | $2,820,000 | 1.05% |
BVF INC/IL | 2,904,684 | $6,826,000 | 0.89% |
FRAZIER MANAGEMENT LLC | 1,312,258 | $3,084,000 | 0.80% |
Monashee Investment Management LLC | 480,851 | $1,130,000 | 0.76% |
Aisling Capital LLC | 1,021,148 | $2,400,000 | 0.68% |
Trellus Management Company, LLC | 94,143 | $221,000 | 0.50% |
Prosight Management, LP | 245,764 | $578,000 | 0.30% |